367 related articles for article (PubMed ID: 32519534)
1. LncRNA OIP5-AS1 induces epithelial-to-mesenchymal transition and renal fibrosis in diabetic nephropathy via binding to miR-30c-5p.
Fu JX; Sun GQ; Wang HL; Jiang HX
J Biol Regul Homeost Agents; 2020; 34(3):961-968. PubMed ID: 32519534
[TBL] [Abstract][Full Text] [Related]
2. MiR-30c-5p inhibits high glucose-induced EMT and renal fibrogenesis by down-regulation of JAK1 in diabetic nephropathy.
Gao BH; Wu H; Wang X; Ji LL; Chen C
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1338-1349. PubMed ID: 32096183
[TBL] [Abstract][Full Text] [Related]
3. LncRNA OIP5-AS1 accelerates ox-LDL-treated HUVECs injury by NF-κB pathway via miR-30c-5p.
Zhang L; Li Q; Chen Y; Zhu Q
Clin Hemorheol Microcirc; 2021; 78(4):449-460. PubMed ID: 33867356
[TBL] [Abstract][Full Text] [Related]
4. miR-30b-5p modulate renal epithelial-mesenchymal transition in diabetic nephropathy by directly targeting SNAI1.
Wang Y; Liu Y; Zhang L; Bai L; Chen S; Wu H; Sun L; Wang X
Biochem Biophys Res Commun; 2021 Jan; 535():12-18. PubMed ID: 33383483
[TBL] [Abstract][Full Text] [Related]
5. MiR-30c protects diabetic nephropathy by suppressing epithelial-to-mesenchymal transition in db/db mice.
Zhao Y; Yin Z; Li H; Fan J; Yang S; Chen C; Wang DW
Aging Cell; 2017 Apr; 16(2):387-400. PubMed ID: 28127848
[TBL] [Abstract][Full Text] [Related]
6. lncRNA ZEB1-AS1 inhibits high glucose-induced EMT and fibrogenesis by regulating the miR-216a-5p/BMP7 axis in diabetic nephropathy.
Meng Q; Zhai X; Yuan Y; Ji Q; Zhang P
Braz J Med Biol Res; 2020; 53(4):e9288. PubMed ID: 32294702
[TBL] [Abstract][Full Text] [Related]
7. LncRNA Opa interacting protein 5-antisense RNA 1 (OIP5-AS1) promotes the migration, invasion and epithelial-mesenchymal transition (EMT) through targeting miR-147a/insulin-like growth factor 1 receptor (IGF1R) pathway in cervical cancer tissues and cell model.
Zhang L; Cai Y; Tian C; Li Y; Ma K; Gao X; Liu L; Jiang Y; Wen W; Ma Z
J Obstet Gynaecol Res; 2022 May; 48(5):1222-1232. PubMed ID: 35233882
[TBL] [Abstract][Full Text] [Related]
8. Up-regulating lncRNA OIP5-AS1 protects neuron injury against cerebral hypoxia-ischemia induced inflammation and oxidative stress in microglia/macrophage through activating CTRP3 via sponging miR-186-5p.
Chen Y; Liu W; Chen M; Sun Q; Chen H; Li Y
Int Immunopharmacol; 2021 Mar; 92():107339. PubMed ID: 33516048
[TBL] [Abstract][Full Text] [Related]
9. LncRNA MALAT1 facilities high glucose induced endothelial to mesenchymal transition and fibrosis via targeting miR-145/ZEB2 axis.
Liu B; Qiang L; Wang GD; Duan Q; Liu J
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3478-3486. PubMed ID: 31081103
[TBL] [Abstract][Full Text] [Related]
10. LncRNA lnc-ISG20 promotes renal fibrosis in diabetic nephropathy by inducing AKT phosphorylation through miR-486-5p/NFAT5.
Duan YR; Chen BP; Chen F; Yang SX; Zhu CY; Ma YL; Li Y; Shi J
J Cell Mol Med; 2021 Jun; 25(11):4922-4937. PubMed ID: 33939247
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of lncRNA-PAX8-AS1-N directly associated with VEGF/TGF-β1/8-OhdG enhances podocyte apoptosis in diabetic nephropathy.
Shen Y; Tong ZW; Zhou Y; Sun Y; Xie Y; Li R; Liu H
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6864-6872. PubMed ID: 32633379
[TBL] [Abstract][Full Text] [Related]
12. LncRNA OIP5-AS1 reduces renal epithelial cell apoptosis in cisplatin-induced AKI by regulating the miR-144-5p/PKM2 axis.
Chang S; Chang M; Liu G; Xu D; Wang H; Sun R; Feng M
Biomed J; 2022 Aug; 45(4):642-653. PubMed ID: 34311128
[TBL] [Abstract][Full Text] [Related]
13. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA OIP5-AS1 serves as an oncogene in laryngeal squamous cell carcinoma by regulating miR-204-5p/ZEB1 axis.
Wang H; Qian J; Xia X; Ye B
Naunyn Schmiedebergs Arch Pharmacol; 2020 Nov; 393(11):2177-2184. PubMed ID: 32009213
[TBL] [Abstract][Full Text] [Related]
15. LncRNA-NR_033515 promotes proliferation, fibrogenesis and epithelial-to-mesenchymal transition by targeting miR-743b-5p in diabetic nephropathy.
Gao J; Wang W; Wang F; Guo C
Biomed Pharmacother; 2018 Oct; 106():543-552. PubMed ID: 29990842
[TBL] [Abstract][Full Text] [Related]
16. Kockdown of OIP5-AS1 expression inhibits proliferation, metastasis and EMT progress in hepatoblastoma cells through up-regulating miR-186a-5p and down-regulating ZEB1.
Zhang Z; Liu F; Yang F; Liu Y
Biomed Pharmacother; 2018 May; 101():14-23. PubMed ID: 29475118
[TBL] [Abstract][Full Text] [Related]
17. Silencing of long noncoding RNA XIST protects against renal interstitial fibrosis in diabetic nephropathy via microRNA-93-5p-mediated inhibition of CDKN1A.
Yang J; Shen Y; Yang X; Long Y; Chen S; Lin X; Dong R; Yuan J
Am J Physiol Renal Physiol; 2019 Nov; 317(5):F1350-F1358. PubMed ID: 31545928
[TBL] [Abstract][Full Text] [Related]
18. LncRNA OIP5-AS1 affects the biological behaviors of chondrocytes of patients with osteoarthritis by regulating micro-30a-5p.
Qin GH; Yang WC; Yao JN; Zhao Y; Wu XJ
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1215-1224. PubMed ID: 33629291
[TBL] [Abstract][Full Text] [Related]
19. lncRNA MSC-AS1 Aggravates Diabetic Nephropathy by Regulating the miR-325/CCNG1 Axis.
Zhao H; Cui Y; Dong F; Li W
J Healthc Eng; 2022; 2022():2279072. PubMed ID: 35126911
[TBL] [Abstract][Full Text] [Related]
20. LncRNA OIP5-AS1 modulates the proliferation and apoptosis of Jurkat cells by sponging miR-181c-5p to regulate IL-7 expression in myasthenia gravis.
Wang X; Zhang H; Lu X; Li S; Kong X; Liu L; Li L; Xu S; Wang T; Wang J; Wang L
PeerJ; 2022; 10():e13454. PubMed ID: 35602889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
